Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 15 Rectal Neoplasms 4 Colonic Neoplasms 3 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Biliary Tract Neoplasms 2 Rhabdomyosarcoma 1 Rare Tumour 1 Pathologic Complete Response 1 Pancreatic Cancer Resectable 1 Neuroblastoma 1 Neoplasms, Second Primary 1 Neoplasm, Residual 1 Medulloblastoma 1 Lung Neoplasms 1 Locally Advanced Low Rectal Adenocarcinoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Cirrhosis, Familial, with Pulmonary Hypertension 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Neuroendocrine 1 CRC 1 Biliary Cancer Metastatic 1 Appendiceal Neoplasms 1 Advanced Malignant Neoplasm 1 Advanced Esophageal Carcinoma 1

Interventions

spartalizumab 1 Radiosurgery 1 Oncolytic Virotherapy 1 Leucovorin 1 Irinotecan 1 IFL protocol 1 HLX07 1 Fluorouracil 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × CRC × Irinotecan × Clear all

NCT07381309 2026-04-28

VVSHIP

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Not yet recruiting

Gastrointestinal

CRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡